Green Organic Dutchman reports wider quarterly losses as cannabis production ramps up
The Green Organic Dutchman, a Toronto-based cannabis cultivator, reported a net loss of 14.1 million Canadian dollars ($10.6…
News May 15
Latest In: Stocks
Marijuana firm Tilray revenue up nearly 200% in Q1; net loss grows on spending
Tilray, a British Columbia, Canada-based cannabis cultivator and distributor, reported revenue of $23 million for the first quarter…
News May 14
CannTrust’s Q1 revenue doubles on medical marijuana sales; net income up
Ontario, Canada-based CannTrust Holdings reported that first-quarter revenue more than doubled from a year earlier, mostly on the…
News May 14
Acreage to sell cannabis real estate assets to newly formed REIT
New York-based marijuana company Acreage Holdings said it agreed to sell cannabis-related real estate to a newly formed…
News May 14
Marijuana company Columbia Care reports improved Q1 revenue, wider net loss
Columbia Care, a New-York based vertically integrated cannabis operator, reported revenue of $12.9 million for the first quarter…
News May 14
Cannabis firm Harvest Health closes $100 million tranche of private placement
Multistate marijuana firm Harvest Health & Recreation (CSE: HARV) closed the initial tranche of its previously announced private…
News May 14
Marijuana Business This Week: NY lawmakers race the clock, Minnesotans mobilize for adult use, earnings watch & more
Here are some notable stories and events in the cannabis industry to watch for in the coming days.
News May 13
Cannabis group Greenlane reports net loss amid expansion
Greenlane, a Florida-based distributor of vape products, reported improved revenue of $49.9 million for the first quarter 2019,…
News May 10
Cannabis firm Cronos Group misses on revenue, reports wider Q1 loss
Toronto-based Cronos Group reported first-quarter results Thursday revealing the licensed marijuana company’s losses grew from a year ago…
News May 9
Epidiolex, Sativex maker GW Pharma reports Q1 revenue, loss improvement
United Kingdom-based GW Pharmaceuticals showed revenue of $39.2 million for the quarter ended March 31, 2019, compared with…
News May 6
Latest Sponsored
